← Back to Research Papers

Quality of life and functional recovery after venous stent placement for postthrombotic syndrome: insights from the ARIVA multinational randomized trial.

Authors: Barco S, Wolf S, Sebastian T, Fumagalli RM, Micieli E, Erbel C, Jalaie H, Klok FA, Schlager O, Kucher N
Journal: Research and practice in thrombosis and haemostasis
mental health psychology open access

Abstract

India is among the world's largest economies, with a nominal Gross Domestic product (GDP) of approximately ∼US $ 3.7–3.8 trillion and is projected to become the third largest in the world with an estimated GDP of $7.3 trillion by 2030 []. As India's economy grows, the country is focusing more on sustainability and innovation, with the bioeconomy emerging as a critical pillar for development. Bioeconomy is defined as the production, utilisation and conservation of biological resources, knowledge and technologies to provide products and services across all economic sectors []. It encompasses a wide range of sectors including biofuel, agriculture, forestry, food and beverages, climate change mitigation and adaptation. Building a globally competitive bioeconomy is both feasible and strategic for India, given its unique strengths. The country is already ranked among the top 12 destinations worldwide in biotechnology with an approximate 3% share in the global biotech industry []. It hosts the 3rd largest start‐up ecosystem globally and is recognised as the largest vaccine manufacturer []. These advantages are further complemented by India's extensive coastline stretching over 7500 km and availability of more than 140 million hectares of agricultural land. India's natural resources, along with its strong pharmaceutical industry [] and growing innovation system, creates a good opportunity for building a diverse and resource‐rich bioeconomy that is environment friendly and sustainable. With this context, this review provides an overview of the current status of the bioeconomy and synthetic biology in India. It examines structural shifts within the sector and highlights the role of the BioE3 policy, along with the contributions of the Department of Biotechnology (DBT) and the Biotechnology Industry Research Assistance Council (BIRAC) in shaping the ecosystem. The review also examines how these elements collectively support innovation and translation within the country.